...Tokyo:4502; NYSE:TAK) and Haumann is CMO of Theravance Biopharma Inc....

...Ltd. (Tokyo:4502; NYSE:TAK) and Haumann is CMO at Theravance Biopharma Inc....
...than purifying proteins. C. Simone Fishburn Takeda Pharmaceutical Co. Ltd. Theravance Biopharma Andy...

...clinic to treat COVID-19. New entries this week include therapies from Evelo Biosciences Inc. (NASDAQ:EVLO), Theravance Biopharma Inc....
...ambrisentan Forxiga (Brand), Farxiga (Brand), BMS-512148 (Former compound #), dapagliflozin (Generic), Forxiga (Other) Losmapimod (DUX4 inhibitor) TD-0903 PL8177 BARDA Evelo Biosciences Inc. Theravance Biopharma Inc. Fulcrum...

...other institutions. COVID-19 clinical trials for at least two other JAK inhibitors have been announced. Theravance Biopharma Inc....

...Theravance, Adverum, Moderna price follow-ons With a $148.5 million offering, Theravance Biopharma Inc. (NASDAQ:TBPH) was among at least...
...CXC chemokine receptor 4 TREM1 - Triggering receptor expressed on myeloid cells 1 BioCentury Staff Adverum Biotechnologies Inc. Theravance Biopharma Inc. Inotrem...

...Biotherapeutics Inc. (OTCQB:NWBO) $95.0 Mission Therapeutics Ltd. $85.7 Viamet Pharmaceuticals Inc. $60.0 Genomics plc $58.1 Theravance Biopharma Inc....

...Theravance gains $10M upfront in Pfizer deal Theravance Biopharma Inc. (NASDAQ:TBPH) granted Pfizer Inc. (NYSE: PFE) exclusive, worldwide...
...Programmed cell death 1 ligand; PSMA (FOLH1; GCPII) - Prostate-specific membrane antigen Hongjiang Li, Staff Writer KN035, 3D-2-02-0015 Theravance Biopharma Inc. Pfizer...

...strategic portfolio advice and review committee. Suliman was SVP of corporate development and strategy at Theravance Biopharma Inc....

...and COO, as well as CSO. Prior to BlackThorn’s founding, he was executive director at Theravance Biopharma Inc....

...Biotherapeutics Inc. (OTCQB:NWBO) $95.0 Mission Therapeutics Ltd. $85.7 Viamet Pharmaceuticals Inc. $60.0 Genomics plc $58.1 Theravance Biopharma Inc....